Glimepiride's Glucose-Lowering Action Peaks at 2-3 Hours
The glucose-lowering action of glimepiride reaches its maximal effect approximately 2-3 hours after oral administration, as measured by minimum blood glucose concentrations. 1
Pharmacodynamic Profile
According to FDA labeling data, in healthy subjects, the time to reach maximal effect (minimum blood glucose concentrations) was approximately 2-3 hours after single oral doses of glimepiride 1. This peak effect timing is consistent across both healthy volunteers and patients with type 2 diabetes.
Key Timing Considerations:
- Peak drug concentration (Cmax): Occurs at 2-3 hours post-dose 1
- Peak glucose-lowering effect: Occurs at approximately 2-3 hours, with maximal insulin secretion occurring around 2.5 hours after administration 2
- Greatest blood glucose lowering effects: Occur within the first 4 hours after dosing 3
Clinical Implications
The relatively rapid onset of action makes glimepiride suitable for once-daily dosing, typically taken with the first main meal of the day 4. This timing allows the peak glucose-lowering effect to coincide with postprandial glucose excursions.
Important Caveats:
- Food effects are minimal: When taken with meals, Cmax and AUC decrease by only 8% and 9% respectively, so food does not significantly alter the timing of peak effect 1
- Hypoglycemia risk: The peak effect at 2-3 hours means patients are at highest risk for hypoglycemia during this window, particularly if meals are delayed or skipped
- Dose-independent timing: The time to peak effect remains consistent across the 1-8 mg dose range, though the magnitude of effect increases with dose 1